Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Progressive multifocal leukoencephalopathy after interferon beta-1a monotherapy.

Literature DB >> 25578178

Progressive multifocal leukoencephalopathy after interferon beta-1a monotherapy.

Helmar C Lehmann¹, Klaus Krüger, Gereon R Fink, Michael Schroeter.

Abstract

Mesh：

Substances：

Year: 2015 PMID： 25578178 DOI： 10.1007/s00415-014-7620-4

Source DB: PubMed Journal: J Neurol ISSN： 0340-5354 Impact factor: 4.849

× No keyword cloud information.

11 in total

1. Common variable immunodeficiency: clinical and immunological features of 248 patients.

Authors: C Cunningham-Rundles; C Bodian
Journal: Clin Immunol Date: 1999-07 Impact factor: 3.969

Review 2. Successful treatment of acute encephalomyelitis associated with common variable immunodeficiency syndrome (CVID): case report and review of the literature.

Authors: S Happe; I W Husstedt
Journal: J Neurol Date: 2000-07 Impact factor: 4.849

3. Treatment de-escalation after mitoxantrone therapy: results of a phase IV, multicentre, open-label, randomized study of subcutaneous interferon beta-1a in patients with relapsing multiple sclerosis.

Authors: Peter Rieckmann; Fedor Heidenreich; Michael Sailer; Uwe K Zettl; Norbert Zessack; Hans-Peter Hartung; Ralf Gold
Journal: Ther Adv Neurol Disord Date: 2012-01 Impact factor: 6.570

4. Atypical PML leading to a diagnosis of common variable immunodeficiency.

Authors: Michael D Snyder; Gregory A Storch; David B Clifford
Journal: Neurology Date: 2005-05-10 Impact factor: 9.910

5. Progressive multifocal leukoencephalopathy in a patient with common variable immunodeficiency.

Authors: P G Scotton; A Vaglia; A Carniato; G C Marchiori
Journal: Clin Infect Dis Date: 1998-01 Impact factor: 9.079

6. Encephalomyelitis in primary hypogammaglobulinaemia.

Authors: P Rudge; A D Webster; T Revesz; T Warner; T Espanol; C Cunningham-Rundles; N Hyman
Journal: Brain Date: 1996-02 Impact factor: 13.501

Review 7. Common variable immunodeficiency: a new look at an old disease.

Authors: Miguel A Park; James T Li; John B Hagan; Daniel E Maddox; Roshini S Abraham
Journal: Lancet Date: 2008-08-09 Impact factor: 79.321

8. Progressive multifocal leukoencephalopathy in a patient with common variable immunodeficiency and abnormal CD8+ T-cell subset distribution.

Authors: Shilpi Narula; David F LaRosa; Malek Kamoun; Josep Dalmau; Arnold I Levinson
Journal: Ann Allergy Asthma Immunol Date: 2007-05 Impact factor: 6.347

9. Treatment of progressive multifocal leukoencephalopathy associated with natalizumab.

Authors: Werner Wenning; Aiden Haghikia; Jörg Laubenberger; David B Clifford; Peter F Behrens; Andrew Chan; Ralf Gold
Journal: N Engl J Med Date: 2009-09-10 Impact factor: 91.245

10. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria.

Authors: Chris H Polman; Stephen C Reingold; Brenda Banwell; Michel Clanet; Jeffrey A Cohen; Massimo Filippi; Kazuo Fujihara; Eva Havrdova; Michael Hutchinson; Ludwig Kappos; Fred D Lublin; Xavier Montalban; Paul O'Connor; Magnhild Sandberg-Wollheim; Alan J Thompson; Emmanuelle Waubant; Brian Weinshenker; Jerry S Wolinsky
Journal: Ann Neurol Date: 2011-02 Impact factor: 10.422

5 in total

Review 1. Treatment-Related Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis: A Comprehensive Review of Current Evidence and Future Needs.

Authors: Emanuele D'Amico; Aurora Zanghì; Carmela Leone; Hayrettin Tumani; Francesco Patti
Journal: Drug Saf Date: 2016-12 Impact factor: 5.606